Skip to content

Comparison of folic acid and folate consumption on ovarian reserve parameters and IVF results

Comparison of folic acid and folate consumption on ovarian reserve parameters and IVF results in women referred to infertility clinic - a randomized, blinded clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180409039247N7
Enrollment
280
Registered
2023-07-31
Start date
2023-08-23
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility. Female infertility

Interventions

Intervention 1: Intervention group: oral folate tablets 600 micrograms daily. Intervention 2: Control group: 1 mg oral folic acid tablet.

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 40 Years

Inclusion criteria

Inclusion criteria: Infertile women aged 30-40 with poor response or unknown causes of infertility are candidates for IVF

Exclusion criteria

Exclusion criteria: Infertility due to PCO; endometriosis; tubal and uterine and having causes of male infertility History of ovarian or pelvic surgery or medical history of chemotherapy or radiotherapy. Diseases associated with viral infections (hepatitis), tumors, autoimmune diseases, endocrine disorders, metabolic disorders or acute inflammation. Patients with definite diagnosis of hereditary diseases or family history of hereditary thrombophilic diseases in family or person. History of multivitamin use

Design outcomes

Primary

MeasureTime frame
Primary outcome: changes in the number of antral follicles. Secondary outcome: changes in FSH, AMH and Inhibin B and checking the level of possible side effects. Timepoint: The results will be evaluated at the beginning of the study and after three months from the start of the study. Method of measurement: To check AFC vaginal ultrasound and to measure FSH, AMH and Inhibin laboratory (blood sample) will be used.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarjan Ghaemi

Tehran University of Medical Sciences

marjan_ghaemi@yahoo.com+98 912 196 7735

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026